I stick to a buy for HUYA after analyzing its latest quarterly performance. HUYA's Q2 topline surpassed expectations, thanks to a 34.2% YoY surge in game-related sales. The firm was also profitable on a non-GAAP basis in Q2 '25, representing the 6th consecutive quarter this feat has been achieved.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.

Global military expenditure climbed by nearly 10% between 2023 and 2024, reaching $2.7 trillion last year as spending accelerated faster since the Cold War. Ongoing conflicts throughout Eastern Europe and the Middle East threaten to continue driving a worldwide race toward defense growth into the foreseeable future.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Kinross Gold has surged 70% in six months, fueled by strong earnings, high gold prices, and project execution.

MIR, BWXT and GEV delivered upbeat Q2 results and raised outlooks, fueling optimism for nuclear energy OEMs in the AI-driven power boom.

Coterra Energy delivered strong Q2 free cash flow and production, overcoming lower commodity prices and operational setbacks in its Harkey wells. Operational resilience, cost discipline, and robust hedging offset challenges, positioning CTRA for higher production and free cash flow in 2025-2026. Favorable natural gas storage and regional supply dynamics support a bullish outlook for CTRA's gas-weighted portfolio heading into winter.

Shares of Palantir Technologies Inc. (NASDAQ:PLTR) lost 5.06% over the past five trading sessions.

Energi to acquire 51% of Tembo with VivoPower continuing to hold a significant shareholding in Tembo post-SPAC merger Energi is supportive of Tembo's business combination with Cactus Acquisition Corp 1 Limited (“SPAC”) at an equity valuation of $838 million Tembo can now resume finalizing and filing the F-4 SPAC Registration Statement LONDON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ: VVPR) (“VivoPower” or the “Company”) today announced it has reached agreement with Energi Holdings Limited (“Energi”) whereby Energi will proceed to secure a 51% shareholding in Tembo e-LV B.V. (“Tembo”) via a strategic PIPE investment at the previously …

The Home Depot, Inc. HD will release earnings results for the second quarter, before the opening bell on Tuesday, Aug. 19.

I am initiating coverage of KCE with a Buy rating, expecting continued outperformance vs. the S&P 500. SPDR S&P Capital Markets ETF's strong historical returns are impressive, especially given its focus on financials and lack of mega-cap tech exposure. The ETF is well-diversified, with 62 holdings across a number of subsectors.

Last week, the S&P 500 experienced a rally that took it to three consecutive record highs. But the momentum cooled as economic data painted a complex picture.

Extrovis AG Bahnhof Park 46340, Baar, Switzerland Media Relations Contact Madhu Marur [email protected] Press Release Extrovis AG and Dr. Reddy's announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Baar, Switzerland; August 14, 2025 Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced the launch of Fluorouracil Cream, 0.5%, an authorized generic and therapeutic equivalent of Carac® (fluorouracil cream) 0.5%, in the US market, approved by the U.S. …

ENGLEWOOD, Colo. , Aug. 18, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the arrival of newly appointed CEO, Steven Dyson, and the appointment of several new leaders at the Company.

Not all REITs are worth buying. Some of the most popular REITs are also the least attractive. I highlight one very overrated REIT and a better alternative.

Move Strengthens Strategic Ties with the Association for Uncrewed Vehicle Systems International and Advances Trusted Operator Initiatives Move Strengthens Strategic Ties with the Association for Uncrewed Vehicle Systems International and Advances Trusted Operator Initiatives

ROLLING MEADOWS, Ill. , Aug. 18, 2025 /PRNewswire/ -- Arthur J.

LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- July 9, 2025 -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 12, 2024 and June 30, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before September 8, 2025.